Clinical Characteristics and Prognostic Factors of Severe COVID-19

Yun Yang1, Ziyi Huang1, Yongjian Pei1

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215004, People's Republic of China.

PubMed

Insights

Severe COVID-19 patients with high white blood cell (WBC) count, platelet (PLT) count, APACHE II score, and mechanical ventilation (MV) have a higher mortality risk. These factors combined offer strong predictive value for COVID-19 patient outcomes.

Area of Science:

  • Clinical Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Coronavirus disease-2019 (COVID-19) presents a significant global health challenge with high mortality rates.
  • Severe COVID-19 cases impose a substantial economic burden worldwide.
  • Early identification of severe cases is crucial for improving patient prognosis and reducing mortality.

Purpose of the Study:

  • To investigate the clinical characteristics of patients with severe COVID-19.
  • To identify prognostic factors associated with mortality in severe COVID-19.
  • To develop a predictive model for early identification of high-risk severe COVID-19 cases.

Main Methods:

  • Retrospective analysis of clinical data from 98 severe COVID-19 patients.
  • Classification of patients into survivors and non-survivors based on hospitalization outcomes.
  • Univariate and multivariate logistic regression analyses to identify risk factors.
  • Receiver operating characteristic (ROC) curve analysis to evaluate predictive values.

Main Results:

  • Non-survivors exhibited higher white blood cell (WBC) count, platelet (PLT) count, APACHE II score, and neutrophil count compared to survivors.
  • Non-survivors had increased incidence of acute kidney injury (AKI), mechanical ventilation (MV), and continuous renal replacement therapy (CRRT).
  • Independent risk factors for poor prognosis included elevated WBC count (AUC=0.807), PLT count (AUC=0.690), APACHE II score (AUC=0.761), and MV (AUC=0.751).
  • Combined risk factors demonstrated a high predictive value with an AUC of 0.897.

Conclusions:

  • Elevated WBC count, PLT count, APACHE II score, and the need for MV are independent predictors of mortality in severe COVID-19.
  • These clinical indicators, particularly when assessed collectively, provide robust predictive value for identifying patients at high risk of mortality.
  • Early recognition of these factors can guide timely interventions to improve outcomes for severe COVID-19 patients.
Abstract

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
453
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
603
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
50